BEVERLY WELLS: Open Payments
NPI 1922155795 · MILLSBORO, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$890 in 44 payments from 14 companies in 2025. Trend: 2023 $66 · 2024 $0 · 2025 $890
Food & beverage: $890
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $255 |
| Lilly USA, LLC | 8 | $184 |
| Novartis Pharmaceuticals Corporation | 3 | $63 |
| PFIZER INC. | 2 | $61 |
| ABBVIE INC. | 3 | $57 |
| Galderma Laboratories, L.P. | 3 | $56 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| Novo Nordisk Inc | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
Products named: TREMFYA, TALTZ, Rhapsido, NEMLUVIO, DUPIXENT, Ozempic, LITFULO, CIBINQO.
Industry payments across DE — which companies pay providers there.
